Name: UMIN ID:
Unique ID issued by UMIN | UMIN000028488 |
---|---|
Receipt number | R000032596 |
Scientific Title | The single-arm phase II study evaluating pomalidomide-plus-dexamethasone for relapsed/refractory multiple myeloma and phase II study evaluating pomalidomide-bortezomib-dexamethasone for the patients who are not able to achieve PR after pomalidomide-plus-dexamethasone therapy |
Date of disclosure of the study information | 2017/08/02 |
Last modified on | 2022/10/09 17:16:21 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/08/02 08:41:36 | ||
2 | Update | 2017/08/02 13:46:31 | Institutions Date of disclosure of the study information |
|
3 | Update | 2017/08/02 13:48:05 | Date of disclosure of the study information |
|
4 | Update | 2018/01/15 15:11:46 | Recruitment status |
|
5 | Update | 2020/08/08 11:47:20 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
6 | Update | 2020/08/08 11:56:16 | Date of IRB Last follow-up date |
|
7 | Update | 2022/10/09 17:16:21 | Recruitment status |